Scavenger receptor BI (SR-BI) is an HDL receptor. It binds HDL and mediates the uptake of cholesteryl ester from HDL. Early studies have pointed out that the extracellular domain of SR-BI is critical for SR-BI-mediated cholesteryl ester uptake. However, the extracellular loop of SR-BI is large which contains 403 amino acids. The HDL binding site and the modulation of SR-BImediated cholesteryl ester uptake remain to be defined. In this study, using C323G mutant SR-BI, we showed that C323G mutant SR-BI lost its HDL binding and cholesteryl ester uptake activity, indicating that the highly conserved C323 is required for SR-BI-mediated HDL binding and cholesteryl ester uptake. Using a blocking antibody against C323 region, we demonstrated that C323 is directly involved in HDL binding and likely an HDL binding site. Using C323G mutant transgenic mouse model, we further demonstrated that C323 of SR-BI is required for regulating plasma cholesterol levels in vivo. Using redox reagents, we showed that physiological relevant levels of H 2 O 2 up regulated the SR-BImediated cholesteryl ester uptake activity by 65% while GSH or DTT significantly down regulated SR-BI-mediated cholesteryl ester uptake activity by 45%.
Introduction
Scavenger receptor class B type I (SR-BI or Scarb1) is a physiological receptor for high density lipoprotein (HDL) (1-2). It regulates plasma cholesterol levels through a process called reverse cholesterol transport, in which SR-BI uptakes cholesteryl ester from HDL into hepatocytes and subsequently secretes cholesterol from bile. SR-BI-mediated cholesteryl ester uptake is also required for steroidogenesis, in which SR-BI uptakes cholesteryl ester from HDL into endocrine tissues for steroids synthesis (3) (4) (5) (6) (7) . The importance of SR-BI-mediated cholesterol transport has been established in mouse models. Mice deficient in SR-BI have a 2-fold increase in total cholesterol concentration and a 3-fold increase in free cholesterol concentration in circulation, and develop cardiovascular diseases (8) (9) (10) (11) (12) (13) . Mice over expressing SR-BI have lower plasma cholesterol levels (14) (15) (16) (17) and protect against the development of atherosclerosis (18) (19) . A recent report showed that a family with functional mutation in SR-BI has elevated plasma HDL and changes in cholesterol metabolism in macrophages and platelets, indicating a role of SR-BI in human. We previously identified C323 of SR-BI as a highly conserved site in SR-BI. Single site mutation at C323 completely abolishes SR-BI-induced apoptosis (25) and its protection against nitric oxide-induced oxidative cell damage (26) , indicating that the C323 is critical for its functions. Interestingly, our study also showed that the mutation at C323 does not affect the ability of SR-B to suppress LPS-induced inflammatory response in macrophages (28). These studies indicate that SR-BI is a multifunctional molecule and C323 may play different roles in modulating the functions of SR-BI. In this study, we demonstrated that C323 is involved in HDL binding and required for SR-BI-mediated cholesteryl ester uptake.
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Materials and methods
Materials -Anti-SR-BI serum was custom made by Sigma-Genosys using a 15 amino acid-peptide derived from the C-terminal of human SR-BI. Blocking antibody against C323 region was generated by Sigma-Genosys using a 15-amino acid-peptide PNEGFCPCLESGIQN conjugated to KLH. The blocking antibody and non-immune serum were affinity purified with a protein A column.
Enzymatic Deglycosylation Kit was from Calbiochem. Cell surface protein isolation kit was from Pierce Biotechnology. Serum total and free cholesterol quantification kits were from Wako.
Generation of transgenic mice -SR-BI and SR-BIC323G transgenic mice were generated as previously described (28 (21) . CHO cells stably expressing C251G, C280G, C321G, G327A, C334G and C384G were generated using the same method. The cells were cultured in
Ham's F-12 medium containing 5% FBS, 2 mmol/L L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.5 mg/ml G418.
Isolation of caveolae -Caveolae, cytosol, and internal membranes were isolated using Opti-Prep method as described previously (7, 8) . This method generates a highly purified fraction of caveolae that is enriched in caveolin-1 and free of bulk plasma membrane markers. Deglycosylation -Cell lysates were deglycosylated by using the enzymatic deglycosylation kit following the manufacturer's instructions. After deglycosylation, samples were analyzed by Western blot.
Lipoprotein profiling by fast protein liquid chromatography (FPLC) -Serum (50 µl) was resolved by gel filtration chromatography with FPLC equipped with a Superose 6 column (Pharmacia LKB Biotechnology Inc.). The column was eluted at a flow rate of 0.5 ml/min and 0.5 ml/fraction was collected. One hundred microliters of sample was mixed with 100µl of 2x assay reagent to determine the cholesterol content of fractions (Wako Chemicals).
Results
SR-BIC323G was located in caveolae on plasma membrane -CHO cell system
has been widely used to study the functions of SR-BI, including SR-BI-mediated HDL binding and cholesteryl ester uptake. Thus, we employed CHO-SR-BIC323G cells to determine the importance of C323 in HDL binding and cholesteryl ester uptake. We first verified membrane targeting of C323G mutant SR-BI with biotin labeling assay. About 40% of SR-BIC323G appeared in cell surface fraction and 60% of SR-BIC323G appeared in non-labeled fraction, which is similar to wild type SR-BI (Fig. 1a ).
We observed a higher molecular weight (100 kDa) band in the lysate of CHO-SR-BIC323G cells and this higher molecular weight (105 kDa) band also appeared in the biotin-labeled fractions from both wild type and C323G mutant SR-BI. We speculated that this higher molecular weight SR-BI band is highly the size of non-glycosylated SR-BI, indicating that the 100 kDa band is highly glycosylated SR-BI. Of note, the 75 kDa band appeared in deglycosylated sample was considered as non-specific band because CHO-vector also displayed such a band (Fig. 1b) .
SR-BI has been shown to locate in caveolae. So we verified its caveola targeting with Opti-prep analysis using caveolin-1 as a marker of caveola. Optiprep analysis showed that C323G mutant SR-BI is colocalized with caveolin-1, indicating that SR-BIC323G is located in caveolae on plasma membrane (Fig.   1c) .
C323 was required for SR-BI-mediated HDL binding, cholesteryl ester uptake
and cholesterol efflux-We conducted HDL binding and cholesteryl ester uptake assay using CHO-SR-BIC323G cells. In contrast to wild type SR-BI which binds HDL and significantly promotes cholesteryl ester uptake, the C323G mutant lost most SR-BI-mediated HDL binding and cholesteryl ester uptake activity, similar to the levels of CHO-vector cells, indicating C323 is required for HDL binding and SR-BI-mediated cholesteryl ester uptake ( Fig. 2a and 2b ).
In addition to mediating cholesteryl ester uptake from HDL, SR-BI also has the ability to stimulate the release of free cholesterol from cells (37) . In order to determine whether C323G alters SR-BI-mediated cholesterol efflux, CHO-SR-BIC323G cells were assayed for their ability to promote efflux of cholesterol to
HDL. Compared with CHO-SR-BI cells, CHO-SR-BIC323G cells displayed
significantly reduced levels of cholesterol efflux to HDL, similar to the levels of CHO-vector cells (Fig. 2c) . The data indicate that C323 is also required for SR-BI-mediated cholesterol efflux.
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To determine whether C323 is directly involved in HDL binding, we generated a blocking antibody using a 15 amino acid-peptide flanking C323. As shown in Fig. 3a and 3b, the blocking antibody abolished SR-BI-mediated HDL binding and cholesteryl ester uptake activity in a dose-dependent manner. The blocking antibody worked as efficiently as unlabeled HDL did. These data suggest that C323 is likely an HDL binding site.
C323 of SR-BI was required for regulating plasma cholesterol levels in mice -To
determine the role of C323 in vivo, we generated transgenic mice expressing wild type and C323G mutant SR-BI (Fig. 4a) . To exclude the effect of endogenous
SR-BI, we used transgenic mice in SR-BI -/-background. When assessed by
Western blot, the wild type SR-BI expressed as a single band at 75kDa and C323G mutant SR-BI expressed as two bands at 75kDa and 100kDa in the liver (Fig. 4b) . As we expected, transgenic expression of wild type SR-BI in SR-BI -/-SR-BI-wt-tg mice significantly reduced the total and free cholesterol levels compared with SR-BI -/-non-tg littermates (Fig. 4c) A potential problem with the point mutation approach is that a single site mutation may disrupt the conformation of a protein resulting in loss of function.
The following two pieces of evidence suggest that it may not the case for SR-BIC323G mutant. 1) Our early study showed that SR-BIC323G mutant still has full activity of suppressing LPS-induced inflammatory response in macrophages Ia and b) . However, both CHO-SR-BIC321G and CHO-SR-BIC384G cells had almost full HDL binding and cholesterol ester uptake activity (Supplement Fig. Id and e) , indicating that extra glycosylation of SR-BI does not affect HDL binding and cholesterol ester uptake activity.
Different from a reducing environment in the intracellular compartment, the extracellular compartment is highly oxidative (38) . Cysteinyl residues in extracellular compartment can undergo a variety of oxidative modifications. For examples, the cysteinyl residues of many proteins participate in reversible oxidation reactions leading to the formation of disulfides (-S-S-), thiolates (-S-), thiyl radical (-S·) et al., and irreversible oxidation leading to formation of sulfinic acid (-SO 2 H) and sulfonic acid (-SO 3 H). In addition, protein thiols can react to form mixed disulfides between proteins or with extracellular GSH (Sglutathiolation) or other small thiols, or to form S-nitrosthiol derivatives (RSNO).
Given the critical roles of cysteinyl residues in SR-BI-mediated HDL binding and cholesteryl uptake, and the redox regulatory nature of cysteine, we speculated that changes in redox status modulate SR-BI-mediated HDL binding and cholesteryl ester uptake activity. To test this, we conducted HDL binding and cholesteryl ester uptake assays in the presence of redox reagents. We found that H 2 O 2 up regulated the SR-BI-mediated cholesteryl ester uptake activity by 65% 
